Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P. Norman

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Drug News & Perspectives|August 26, 2003
Rational approaches to new drug design in the U.KP Norman
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2001
ZD-1839 (AstraZeneca)P Norman
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
OSI-774 OSI PharmaceuticalsP Norman
Social Science & Medicine (1982)|July 1, 1993
Predicting the uptake of health checks in general practice: invitation methods and patients' health beliefsP Norman
Idrugs : the Investigational Drugs Journal|September 24, 2005
DHEA (Leland Stanford Junior University)P Norman
Idrugs : the Investigational Drugs Journal|May 10, 2008
New Drugs for Asthma--IBC's International Conference. 16-17 June 1998, National Heart & Lung Institute, London, UKP Norman
Drug News & Perspectives|June 24, 2003
The impact of new technologies on drug designP Norman
Drug News & Perspectives|June 19, 2003
New drug targets in inflammation and immunomodulationP Norman
Drug News & Perspectives|June 14, 2003
The changing role of drug metabolism and pharmacokineticsP Norman
Idrugs : the Investigational Drugs Journal|August 30, 2005
Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UKP Norman
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Drug News & Perspectives|August 26, 2003
Rational approaches to new drug design in the U.KP Norman
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2001
ZD-1839 (AstraZeneca)P Norman
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
OSI-774 OSI PharmaceuticalsP Norman
Social Science & Medicine (1982)|July 1, 1993
Predicting the uptake of health checks in general practice: invitation methods and patients' health beliefsP Norman
Idrugs : the Investigational Drugs Journal|September 24, 2005
DHEA (Leland Stanford Junior University)P Norman
Idrugs : the Investigational Drugs Journal|May 10, 2008
New Drugs for Asthma--IBC's International Conference. 16-17 June 1998, National Heart & Lung Institute, London, UKP Norman
Drug News & Perspectives|June 24, 2003
The impact of new technologies on drug designP Norman
Drug News & Perspectives|June 19, 2003
New drug targets in inflammation and immunomodulationP Norman
Drug News & Perspectives|June 14, 2003
The changing role of drug metabolism and pharmacokineticsP Norman
Idrugs : the Investigational Drugs Journal|August 30, 2005
Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UKP Norman
Pageof 26